The aim of this study was (1) to investigate whether MVD as well as p53 expression and VEGF expression are independent prognostic factors for patients with gastric cancer undergoing curative gastrectomy, and (2) to evaluate their predictive value for clinical outcome following adjuvant chemotherapy. This evidence concerns the gene VEGFA and gastric cancer.